JUN 07, 2021 4:00 PM BST

Alinity m STI* with extragenital samples: from assay design to real world experience

Speakers

Abstract

DATE: June 7, 2021

TIME:  4:00pm BST

 

The World Health Organization (WHO) estimates that more than 1 million individuals contract a sexually transmitted infection (STI) every day. The most common STI pathogens are Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). Urogenital infections due to these pathogens can lead to severe consequences in reproductive health and increase the risk of acquiring or transmitting HIV-1 while the extragenital CT and NG infections in the oropharynx and rectum in men and women can serve as a reservoir potentially resulting in future infections and may also lead to severe clinical complications.  Accurate and rapid diagnosis of sexually transmitted infections (STIs) is essential for timely administration of appropriate treatment and reducing the spread of the disease.   This webinar will discuss design and development of Alinity m STI* assay including performance characteristics of Alinity m STI* assay (CT/NG) with extragenital sample types.  

 

Learning objectives:

  • Understand the differences and similarities in clinical manifestation of CT, NG, TV and MG.
  • Learn about the design and development of the Alinity m STI* assay.
  • Learn about performance characteristics of the Alinity m STI* assay (CT/NG) with extragenital sample types.

 

 

*Alinity m STI assay is CE marked and is not commercially available in the U.S.

 

Webinars will be available for unlimited on-demand viewing after live event.


Show Resources
You May Also Like
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
JUN 22, 2021 10:00 AM PDT
C.E. CREDITS
JUN 22, 2021 10:00 AM PDT
Date: June 22, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Antimicrobial resistance (AMR) has emerged as one of the principal public health problems of the 21st century. It threatens the effectiv...
APR 08, 2021 11:00 AM PDT
C.E. CREDITS
APR 08, 2021 11:00 AM PDT
Date: April 8, 2021 Time: 11:00am (PDT), 3:00pm (EDT) Pneumonia is a deadly condition with clinical outcomes highly dependent on prompt and appropriate therapy. Diagnosis of pneumonia is cha...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
Loading Comments...
Show Resources